Advertisement
Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH SEARCH RESULT
 QUICK SEARCH:   [advanced]


     


Botulinum toxin

Citations 1-10 of 31 total displayed.

Most recent content (14 Oct 2008):

VIEWS & REVIEWS
Update on blepharospasm: Report from the BEBRF International Workshop
Mark Hallett, Craig Evinger, Joseph Jankovic, and Mark Stacy
Neurology 2008; 71: 1275-1282. [Abstract] [Full text] [PDF]  

Past content (since Dec 2001):

CLINICAL/SCIENTIFIC NOTES
FINE-MAPPING THE GENE FOR X-LINKED MYOPATHY WITH EXCESSIVE AUTOPHAGY
I. Munteanu, N. Ramachandran, G. N. Mnatzakanian, M. Villanova, M. Fardeau, N. Levy, J. T. Kissel, and B. A. Minassian
Neurology 2008; 71: 951-953. [Full text] [PDF]  

ARTICLES
Two-year placebo-controlled trial of botulinum toxin A for leg spasticity in cerebral palsy
A. P. Moore, R. A. Ade-Hall, C. Tudu Smith, L. Rosenbloom, H.P.J. Walsh, K. Mohamed, and P. R. Williamson
Neurology 2008; 71: 122-128. [Abstract] [Full text] [PDF]  

SPECIAL ARTICLES
Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review): Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
D. M. Simpson, A. Blitzer, A. Brashear, C. Comella, R. Dubinsky, M. Hallett, J. Jankovic, B. Karp, C. L. Ludlow, J. M. Miyasaki, M. Naumann, and Y. So
Neurology 2008; 70: 1699-1706. [Abstract] [Full text] [PDF]  

ARTICLES
Neutralizing antibodies in dystonic patients who still respond well to botulinum toxin type A
G. Kranz, T. Sycha, B. Voller, G. S. Kranz, P. Schnider, and E. Auff
Neurology 2008; 70: 133-136. [Abstract] [Full text] [PDF]  

EDITORIALS
Writer’s cramp: Questions of causation
Joel S. Perlmutter and W. Thomas Thach
Neurology 2007; 69: 331-332. [Full text] [PDF]  

BRIEF COMMUNICATIONS
CDIP-58 can measure the impact of botulinum toxin treatment in cervical dystonia
S. J. Cano, J. C. Hobart, M. Edwards, R. Fitzpatrick, K. Bhatia, A. J. Thompson, and T. T. Warner
Neurology 2006; 67: 2230-2232. [Abstract] [Full text] [PDF]  

BRIEF COMMUNICATIONS
Clinico-immunologic aspects of botulinum toxin type B treatment of cervical dystonia
J. Jankovic, C. Hunter, B. Z. Dolimbek, G. S. Dolimbek, C. H. Adler, A. Brashear, C. L. Comella, M. Gordon, D. E. Riley, K. Sethi, C. Singer, M. Stacy, D. Tarsy, and M. Z. Atassi
Neurology 2006; 67: 2233-2235. [Abstract] [Full text] [PDF]  

BRIEF COMMUNICATIONS
Severe botulism after focal injection of botulinum toxin
N. Souayah, H. Karim, S. S. Kamin, J. McArdle, and S. Marcus
Neurology 2006; 67: 1855-1856. [Abstract] [Full text] [PDF]  

BRIEF COMMUNICATIONS
Botulinum toxin injection for congenital muscular torticollis presenting in children and adults
Abigail Collins and Joseph Jankovic
Neurology 2006; 67: 1083-1085. [Abstract] [Full text] [PDF]  

[Next page]
Pages: 1 2 3 4

* Collected Resources Home

* Related collections:
 Movement Disorders
 All Movement Disorders
 Dystonia
 Blepharospasm
 Gait disorders/ataxia
 Cerebellum
 Huntington's disease
 Basal ganglia
 Parkinson's disease/Parkinsonism
 Motor Control
 Progressive supranuclear palsy
 Motor cortex
 Stiff person syndrome
 Surgery/Stimulation
 Tourette syndrome
 Tremor
 Tics
 Chorea
 Botulinum toxin
 Multiple system atrophy
 Rett Syndrome
 Myoclonus
 Spastic paraplegia


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH SEARCH RESULT
Copyright © 2009 by AAN Enterprises, Inc.
Advertisement